Plague is a bacterial infectious disease caused by Yersinia pestis. It is majorly spread by flea bites and is officially of two types, bubonic and septicemic. Bubonic form leads to swelling of lymph nodes, whereas in septicemic plague, tissue turns dark black. Most frequent symptoms of plague include fever, headache, and shortness of breath. As and when any incidence of human plague is captured, antimicrobial treatment is carried out to counter it. In addition, plague modification devices are available in the market that help in clearing out arterial blockage to improve blood circulation in the body. Arterial plague is due to deposition of fat on the outer wall resulting in reduced blood flow. With the plethora of various organic and inorganic strategies being incorporated by global players, plague modification device market is expected to grow at a notable pace in coming years.
COVID-19 Impact Analysis
Increase has been witnessed in the demand for medical supplies to take care of infected population. Respiratory support devices such as atomizers, life support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. The need for medical supplies has increased significantly among both from healthcare professionals and civil population for precautionary measures, owing to rise in number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the global plaque modification devices market.
Top Impacting Factors
- Rise in number of people suffering from cardiovascular and related diseases around the globe is a major driving factor for market growth.
- Increase in incidence of older populace suffering from obesity, high cholesterol levels, and heart diseases in industrialized regions such as North America and Europe is another primary driver for two-fold market growth.
- Increase in health awareness and rise in per capita income drive the market growth in lower middle income and newly industrialized nations.
- Another factor for growth of plague modification device market is the growing popularity of coronary lithoplasty.
- Introduction of innovative technologies coupled with surge in frequency of adoption of minimal invasive surgeries is expected to drive the market growth.
- However, huge developmental and operational costs associated with market combined with effects of ongoing pandemic are likely to hamper growth of plague modification device market.
Plague Modification Devices Market Trends
- Chronic total occlusion segment is likely to witness remarkable growth due to rising number of patients suffering from chronic heart diseases in under developed nations in Africa and the Middle East.
- North America, the peripheral artery segment is likely to remain as the leading revenue generator, owing to more cases of peripheral artery disease in the region.
- Avinger Technologies is likely to launch Ocelaris CAD, an image guided CTO crossing at the end of this year, thus providing the much needed push for plague modification segment in Asia-Pacific.
- Launch of Pantheris SV and Pantheris Next Gen, which is a joint venture is anticipated to garner huge market traction in North America, entrusting stakeholders of huge opportunity with the growth of plague modification device market.
Key Benefits of the Report
- This study presents the analytical depiction of the plaque modification devices industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the plaque modification devices market share.
- The current market is quantitatively analyzed to highlight the plaque modification devices market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.
Questions Answered in the Plaque Modification Devices Market Report
- Which are the leading players active in the plaque modification devices market?
- How is each segment of the market expected to grow during the forecast period?
- What are the adoption trends for the plaque modification devices market in emerging economies and established economies across the world?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the plaque modification devices market?
- What future projections would help in taking further strategic steps?
- What are the impacts of COVID-19 in the industry?
- What is plaque modification devices?
- What is the plaque modification devices g market prediction in the future?
- What are the current trends and predicted trends?
Key Market Segments
- By Type
- Atherectomy Devices
- Thrombectomy Devices
- Chronic Total Occlusion Devices
- Embolic Protection Devices
- By Application
- Coronary Artery Disease
- Peripheral Artery Disease
- Neurovascular Diseases
- By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
- By Region
- North America
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
Key Market Players
- Medtronic Plc
- Microvention Inc.
- Codman Neuro
- Cardinal Health Inc.
- Stryker Corp.
- B. Braun Melsungen AG
- Biotronik SE and Co. KG
- Boston Scientific Corporation
- Penumbra Inc.
- Cardiovascular Systems Inc